enGene Therapeutics, Inc. (ENGN)
1.585
-0.08
(-5.09%)
USD |
NASDAQ |
Jun 10, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
enGene Therapeutics EPS Diluted (TTM) : -2.254 for Jan. 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| January 31, 2026 | -2.254 |
| October 31, 2025 | -2.295 |
| July 31, 2025 | -1.896 |
| April 30, 2025 | -1.648 |
| January 31, 2025 | -1.522 |
| October 31, 2024 | -1.501 |
| July 31, 2024 | -1.212 |
| April 30, 2024 | -0.8944 |
| January 31, 2024 | -0.6858 |
| September 30, 2023 | -0.2464 |
| Date | Value |
|---|---|
| July 31, 2023 | -0.1575 |
| June 30, 2023 | -0.1498 |
| March 31, 2023 | 0.0052 |
| December 31, 2022 | 0.002 |
| September 30, 2022 | -0.0508 |
| June 30, 2022 | -0.0561 |
| March 31, 2022 | -0.0398 |
| December 31, 2021 | -0.0143 |
| September 30, 2021 | -0.0007 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 2.164 |
| Medicus Pharma Ltd. | -1.780 |
| Xenon Pharmaceuticals, Inc. | -4.705 |
| Psyence Biomedical Ltd. | -6.321 |
| Agenus, Inc. | 1.670 |